1Lok A, McMahon BJ. Chronic hepatitis B. Hepatology 200; 34:1225-1241.
2de Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A,McIntyre N, Mele A, Paumgartner G, Pietrangelo A, Rodes J,Rosenberg W, Valla D. EASL Jury. EASL internationalconsensus conference on hepatitis B. 13-14 september, 2002 genera switzerland consensus statement (long rersion). J Hevatol 2003: 39:S3-25.
3James L, Fong CW, Foong BH, Wee MK, Chow A, Shum E,Chew SK. Hepatitis B seroprevalence study 1999. Singapore Med J 2001; 42:420-424.
4Ministry Of Health, Singapore. Statistics: Health facts Singapore 2002. http://app.moh.gov.sg/sta/sta0202.asp#sta0202. Accessed March 2004.
5Wai CT, Lok ASF. Treatment of hepatitis B. J Gastroenterol 2002; 37:771-778.
6Tang ZY, Yang BH. Secondary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol 1995; 10:683-690.
7McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A,Sacco F, Dunaway E, Williams J. Screening for hepatocellular carcinoma in Alaska Natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000; 32:842-846.
8Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E.Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996; 78:977-985.
9Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y,Kobayashi K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990;12:680-687.
10Core working party for Asia-Pacific consensus on hepatitis B and C. Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region.Core Working Party for Asia-Pacific Consensus on Hepatitis B and C. J Gastroenterol Hepatol 2000; 15:825-841.
